ATYR

aTyr Pharma
ATYR

Overview Fund Activity

52 hedge funds and large institutions have $23.1M invested in aTyr Pharma in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+9
Holders Change %
+20.93%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
11
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EC
1
EcoR1 Capital
California
$2.1M
2
RSCM
2
Rock Springs Capital Management
Maryland
$1.02M
3
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$2.31M
4
VKH
4
Virtu KCG Holdings
New York
$43K
5
AIM
5
Alambic Investment Management
California
$40K

Top Sellers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$2K
2
BFA
2
BlackRock Fund Advisors
California
$88K
3
MF
3
Magnetar Financial
Illinois
$0
4
TAM
4
Tiverton Asset Management
Delaware
$205K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$767K
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
51
IFP Advisors
Florida
$1K – – –
MF
52
Magnetar Financial
Illinois
– -$440K -9,890 Closed
JPC
53
Jackson Park Capital
Utah
– -$210K -4,714 Closed
Deutsche Bank
54
Deutsche Bank
Germany
– -$166K -3,739 Closed
ProShare Advisors
55
ProShare Advisors
Maryland
– -$48K -1,068 Closed
1 2
3